PMC:7319919 / 5592-6155
Annnotations
LitCovid-PD-FMA-UBERON
Id | Subject | Object | Predicate | Lexical cue | fma_id |
---|---|---|---|---|---|
T23 | 269-273 | Body_part | denotes | cell | http://purl.org/sig/ont/fma/fma68646 |
T24 | 358-363 | Body_part | denotes | cells | http://purl.org/sig/ont/fma/fma68646 |
LitCovid-PD-MONDO
Id | Subject | Object | Predicate | Lexical cue | mondo_id |
---|---|---|---|---|---|
T32 | 68-101 | Disease | denotes | severe acute respiratory syndrome | http://purl.obolibrary.org/obo/MONDO_0005091 |
T33 | 196-204 | Disease | denotes | SARS-CoV | http://purl.obolibrary.org/obo/MONDO_0005091 |
T34 | 442-450 | Disease | denotes | SARS-CoV | http://purl.obolibrary.org/obo/MONDO_0005091 |
T35 | 453-462 | Disease | denotes | infection | http://purl.obolibrary.org/obo/MONDO_0005550 |
T36 | 554-562 | Disease | denotes | COVID-19 | http://purl.obolibrary.org/obo/MONDO_0100096 |
LitCovid-PD-CLO
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T60 | 22-25 | http://purl.obolibrary.org/obo/CLO_0051582 | denotes | has |
T61 | 51-59 | http://purl.obolibrary.org/obo/CLO_0001658 | denotes | activity |
T62 | 228-232 | http://purl.obolibrary.org/obo/CLO_0053407 | denotes | ABL2 |
T63 | 263-268 | http://purl.obolibrary.org/obo/NCBITaxon_10239 | denotes | virus |
T64 | 269-273 | http://purl.obolibrary.org/obo/GO_0005623 | denotes | cell |
T65 | 358-363 | http://purl.obolibrary.org/obo/GO_0005623 | denotes | cells |
LitCovid-PD-CHEBI
Id | Subject | Object | Predicate | Lexical cue | chebi_id |
---|---|---|---|---|---|
T45 | 13-21 | Chemical | denotes | imatinib | http://purl.obolibrary.org/obo/CHEBI_45783 |
T46 | 41-50 | Chemical | denotes | antiviral | http://purl.obolibrary.org/obo/CHEBI_22587 |
T47 | 398-406 | Chemical | denotes | imatinib | http://purl.obolibrary.org/obo/CHEBI_45783 |
T48 | 517-526 | Chemical | denotes | antiviral | http://purl.obolibrary.org/obo/CHEBI_22587 |
T49 | 546-550 | Chemical | denotes | drug | http://purl.obolibrary.org/obo/CHEBI_23888 |
LitCovid-PubTator
Id | Subject | Object | Predicate | Lexical cue | tao:has_database_id |
---|---|---|---|---|---|
147 | 139-152 | Species | denotes | coronaviruses | Tax:11118 |
148 | 196-206 | Species | denotes | SARS-CoV-2 | Tax:2697049 |
149 | 334-347 | Species | denotes | coronaviruses | Tax:11118 |
150 | 13-21 | Chemical | denotes | imatinib | MESH:D000068877 |
151 | 398-406 | Chemical | denotes | imatinib | MESH:D000068877 |
152 | 442-462 | Disease | denotes | SARS-CoV-2 infection | MESH:C000657245 |
153 | 554-562 | Disease | denotes | COVID-19 | MESH:C000657245 |
LitCovid-PD-GO-BP
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T11 | 269-280 | http://purl.obolibrary.org/obo/GO_0140253 | denotes | cell fusion |
T12 | 269-280 | http://purl.obolibrary.org/obo/GO_0045026 | denotes | cell fusion |
T13 | 269-280 | http://purl.obolibrary.org/obo/GO_0000768 | denotes | cell fusion |
T14 | 269-280 | http://purl.obolibrary.org/obo/GO_0000747 | denotes | cell fusion |
LitCovid-sentences
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T43 | 0-212 | Sentence | denotes | In addition, imatinib has shown in vitro antiviral activity against severe acute respiratory syndrome and Middle East respiratory syndrome coronaviruses [9], which are phylogenetically related to SARS-CoV-2 [10]. |
T44 | 213-368 | Sentence | denotes | In this sense, ABL2 appears to be involved in the virus-cell fusion process, so its blockage could modulate the entry of coronaviruses into host cells [9]. |
T45 | 369-563 | Sentence | denotes | These data also suggest that imatinib might be useful in early stages of SARS-CoV-2 infection, although further research is needed to ascertain the antiviral properties of this drug in COVID-19. |
LitCovid-PMC-OGER-BB
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T76 | 13-21 | CHEBI:14434;CHEBI:14434 | denotes | imatinib |
T77 | 81-92 | UBERON:0001004 | denotes | respiratory |
T78 | 118-129 | UBERON:0001004 | denotes | respiratory |
T79 | 139-152 | NCBITaxon:11118 | denotes | coronaviruses |
T80 | 196-206 | SP_7 | denotes | SARS-CoV-2 |
T81 | 228-232 | PR:000003583 | denotes | ABL2 |
T82 | 263-268 | NCBITaxon:10239 | denotes | virus |
T83 | 269-280 | GO:0061025 | denotes | cell fusion |
T84 | 312-320 | GO:0065007 | denotes | modulate |
T85 | 334-347 | NCBITaxon:11118 | denotes | coronaviruses |
T86 | 398-406 | CHEBI:14434;CHEBI:14434 | denotes | imatinib |
T87 | 442-452 | SP_7 | denotes | SARS-CoV-2 |
T88 | 546-550 | CHEBI:23888;CHEBI:23888 | denotes | drug |
T89 | 554-562 | SP_7 | denotes | COVID-19 |
T45081 | 13-21 | CHEBI:14434;CHEBI:14434 | denotes | imatinib |
T88775 | 81-92 | UBERON:0001004 | denotes | respiratory |
T61507 | 118-129 | UBERON:0001004 | denotes | respiratory |
T25185 | 139-152 | NCBITaxon:11118 | denotes | coronaviruses |
T11544 | 196-206 | SP_7 | denotes | SARS-CoV-2 |
T8102 | 228-232 | PR:000003583 | denotes | ABL2 |
T86755 | 263-268 | NCBITaxon:10239 | denotes | virus |
T99959 | 269-280 | GO:0061025 | denotes | cell fusion |
T94733 | 312-320 | GO:0065007 | denotes | modulate |
T61456 | 334-347 | NCBITaxon:11118 | denotes | coronaviruses |
T8366 | 398-406 | CHEBI:14434;CHEBI:14434 | denotes | imatinib |
T88154 | 442-452 | SP_7 | denotes | SARS-CoV-2 |
T36497 | 546-550 | CHEBI:23888;CHEBI:23888 | denotes | drug |
T63516 | 554-562 | SP_7 | denotes | COVID-19 |